Tweets
RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by UCB.
All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
2 minutes 31 seconds ago
Reading the Sacroiliac Joint Early: What MRI Reveals in axSpA
Imaging is one of the best tools for catching axSpA sooner, and the 2025 ASAS-SPARTAN revised classification criteria reflect that: the most heavily weighted variable is “MRI indicative of axSpA in the sacroiliac https://t.co/wEcLN8Vq9r
Dr. John Cush @RheumNow ( View Tweet )
28 minutes 2 seconds ago
Spanish retrospective study by Funcia et al on DEN discontinuation & fracture incidence
7% developed fractures after DEN dc
Incr fall risk was the only significant factor identified
Causes of discontinuation: Poor adherence, other causes & AEs
@RheumNow #ACR26 Abs2956 https://t.co/lSSJMrxVuk
Links:
sheila @RHEUMarampa ( View Tweet )
34 minutes 28 seconds ago
In the ALLIANCE randomised trial, 82 physicians worked through three rheumatology vignettes with or without a certified large language model decision support system. The decision support system alone reached 33.3% top diagnosis accuracy against 27.0% for unassisted
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
34 minutes 30 seconds ago
Telehealth RA visits rely on patient-led joint counts, but physician-patient agreement on SJ is weakest (ICC 0.28 vs 0.51 for TJ).
Low-cost hand model + 5min video raised patient confidence checking SJ (median 3 to 4, p<0.01). Accuracy untested.
A#2965 @RheumNow #ACR26 https://t.co/8Sgx0Adxkn
Jiha Lee @JihaRheum ( View Tweet )
34 minutes 34 seconds ago
Prospective cohort study of DEN for OP in RMDs:
Sustained incr in BMD of the lumbar spine
Sustained significant reduxn of bone turnover markers
Pts on GC, DEN significantly incr BMD of the lumbar spine
@RheumNow #ACR26 Abs2954 https://t.co/qoOCXKZ7DX
Links:
sheila @RHEUMarampa ( View Tweet )
1 hour 4 minutes ago
In the phase 2a AFFINITY study of 91 patients with PsA and inadequate response to TNF inhibition, guselkumab plus golimumab reduced the TNF activity score, CRP and IL6, while guselkumab alone showed numerical reductions only. Responders to combination therapy had higher baseline https://t.co/E9gEb8sN2j
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 hour 4 minutes ago
Real-world data fr Northern Ireland (Banford et al) of Romosozumab for severe OP
Pop’n: 22 pts, QRISK 3 scores; no prior MI/stroke
Romo showed sinificant improvement in BMD w/n 12 mos; modest in the hip and higher improvement on lumbar spine BMDs
@RheumNow #ACR26 Abs2953 https://t.co/PZcjbRVdTv
Links:
sheila @RHEUMarampa ( View Tweet )
1 hour 4 minutes ago
ASAS points to consider for difficult to manage, including treatment refractory, axSpA: 4 overarching principles and 10 points, endorsed by 91.3% of ASAS members. Key finding: recommends reassessing diagnosis, confirming inflammation, checking adherence and comorbidities before https://t.co/2JXibesxBm
Links:
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 hour 4 minutes ago
In 60 RA patients, grayscale ultrasound correlated with biopsy inflammation in early and refractory disease. Power Doppler correlated only in early RA. Biopsies with high ultrasound scores but little inflammation often showed scar tissue. #2934 @Rheumnow #ACR26
Mrinalini Dey @DrMiniDey ( View Tweet )
1 hour 4 minutes ago
@RheumNow AI-driven SDOH screening and intervention: Studies are leveraging automation and machine learning to identify unmet social needs and facilitate referrals. Can AI help bridge the gap between screening and action? #ACR2026 Determinates of health and outcomes #5
anita @docdhanrajani ( View Tweet )
1 hour 4 minutes ago
Higher orosomucoid-1 levels were associated with future difficult-to-treat RA in two cohorts (n=198). Samples were taken years before D2T criteria were met. Independent validation using ELISA showed an AUC of 0.86. #2933 @Rheumnow #ACR26
Mrinalini Dey @DrMiniDey ( View Tweet )
1 hour 4 minutes ago
Eosinophilia and RA-ILD
The absolute eosinophil count (AEC) on a routine complete blood count could be a useful addition when deciding which patients to work up for RA-ILD.
https://t.co/MxJTYJCcVk https://t.co/uHP2FwdAmi
Dr. John Cush @RheumNow ( View Tweet )
1 hour 6 minutes ago
RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by Beeline Medicines, Boehringer Ingelheim, Bristol Myers Squibb, and Tonix. All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
1 hour ago
Can We Predict Work Disability in Lupus?
When it comes to managing patients with
SLE there are many aspects of the disease to consider – disease activity, organs involved, and the potential for long term damage. Given that SLE affects many working-age adults, there is another https://t.co/9Fp4MxKpw9
Dr. John Cush @RheumNow ( View Tweet )
2 hours 8 minutes ago